Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 May;34(5):847-856.
doi: 10.1038/s41433-019-0529-5. Epub 2019 Jul 30.

Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services

Francis Mutangana #  1 , Charles Muhizi #  2 , Godelieve Mudereva  3 , Piet Noë  4 , Stephenson Musiime  5 , Tharcisse Ngambe  5 , Lisine Tuyisenge  6 , Muzungu Kumwami  6 , Hovaire Nsabimana  7 , Craig Conard  7 , Yannick Fonteyne  8 , Ingele Casteels  9 , Stefan De Smedt  10 ; Rwanda Retinopathy of Prematurity Study Group
Collaborators, Affiliations
Multicenter Study

Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services

Francis Mutangana et al. Eye (Lond). 2020 May.

Erratum in

Abstract

Objectives: To investigate risk factors for retinopathy of prematurity (ROP) in a newly established ROP screening and management programme in Rwanda, Africa.

Methods: In this multi-centre prospective study 795/2222 (36%) babies fulfilled the inclusion criteria (gestational age (GA) < 35 weeks or birth weight (BW) < 1800 g or unstable clinical course), 424 (53%) of whom were screened for ROP. 270 died before the first screening. ROP and treatment-warranted ROP were classified using the revised International Classification of ROP (2005). Data on maternal and perinatal risk factors were collected from daily neonatal notes.

Results: 31 babies (7.3%, CI 5.0-10.2) developed any ROP, 13 of whom (41.9%, CI 24.5-60.9) required treatment. ROP was seen in six neonates with GA > 30 weeks and BW > 1500 g, one of whom required treatment. In univariate analysis the following were associated with any ROP: increasing number of days on supplemental oxygen (OR 2.1, CI 1.5-3.0, P < 0.001), low GA (OR 3.4, CI 1.8-6.4, P < 0.001), low BW (OR 2.3, CI 1.5-3.4, P < 0.001), at least one episode of hyperglycaemia ≥ 150 mg/dl (OR 6.6, CI 2.0-21.5, P < 0.001), blood transfusion (OR 3.5, CI 1.6-7.4, P < 0.001) or sepsis (OR 3.2, CI 1.2-8.6, P = 0.01). In multivariate analysis longer exposure to supplemental oxygen (OR 2.1, CI 1.2-3.6, P = 0.01) and hyperglycaemia (OR 3.5, CI 1.0-12.4, P = 0.05) remained significant.

Conclusions: ROP has become an emerging health problem in Rwanda, requiring programmes for screening and treatment. ROP screening is indicated beyond the 2013 American Academy guidelines. Improved quality of neonatal care, particularly oxygen delivery and monitoring is needed.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Distribution of retinopathy of prematurity (ROP) cases by birth weight (BW) and gestational age (GA). The grey area represents BW and GA beyond the American Academy 2013 screening criteria (BW ≤ 1500 g and GA ≤ 30 weeks)
See this image and copyright information in PMC

References

    1. Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77–119. doi: 10.1016/j.preteyeres.2017.09.002. - DOI - PubMed
    1. Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350:12–4. doi: 10.1016/S0140-6736(97)01107-0. - DOI - PubMed
    1. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pedia Res. 2013;74(Suppl 1):35–49. doi: 10.1038/pr.2013.205. - DOI - PMC - PubMed
    1. Quinn G, Gilbert C, Darlow B, Zin A. Retinopathy of prematurity: an epidemic in the making. Chin Med J. 2010;123:2929–37. - PubMed
    1. Gilbert C, Fielder A, Gordillo L, Guinn G, Semiglia R, Zin A, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate and high levels of development: implications for screening programs. Pediatrics. 2005;115:e518–e25. doi: 10.1542/peds.2004-1180. - DOI - PubMed

Publication types